<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Therapy</journal-id><journal-title-group><journal-title xml:lang="en">Therapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапия</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2412-4036</issn><issn publication-format="electronic">2713-1823</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">288747</article-id><article-id pub-id-type="doi">10.18565/therapy.2022.1.28-34</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Smell and taste impairment in young adults with COVID-19</article-title><trans-title-group xml:lang="ru"><trans-title>Нарушение обоняния и вкуса у молодых людей с COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Izmozherova</surname><given-names>Nadezhda V.</given-names></name><name xml:lang="ru"><surname>Изможерова</surname><given-names>Надежда Владимировна</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, associate professor, head of the Department of pharmacology and clinical pharmacology, Chief freelance specialist - clinical pharmacologist of the Ministry of Healthcare of the Sverdlovsk Region</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, зав. кафедрой фармакологии и клинической фармакологии, главный внештатный специалист - клинический фармаколог Минздрава Свердловской области</p></bio><email>nadezhdajzm@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Popov</surname><given-names>Artem A.</given-names></name><name xml:lang="ru"><surname>Попов</surname><given-names>Артем Анатольевич</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, associate professor, head of the Department of hospital therapy and emergency medicine</p></bio><bio xml:lang="ru"><p>д.м.н., доцент, зав. кафедрой госпитальной терапии и скорой медицинской помощи</p></bio><email>art_popov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shambatov</surname><given-names>Muraz A.</given-names></name><name xml:lang="ru"><surname>Шамбатов</surname><given-names>Мураз Акбар оглы</given-names></name></name-alternatives><bio xml:lang="en"><p>postgraduate student at the Department of pharmacology and clinical pharmacology</p></bio><bio xml:lang="ru"><p>аспирант кафедры фармакологии и клинической фармакологии</p></bio><email>muraz.shambatov@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Baksheev</surname><given-names>Ivan Yu.</given-names></name><name xml:lang="ru"><surname>Бакшеев</surname><given-names>Иван Юрьевич</given-names></name></name-alternatives><bio xml:lang="en"><p>ophthalmologist</p></bio><bio xml:lang="ru"><p>врач-офтальмолог</p></bio><email>xrayseven1@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Ural State Medical University of the Ministry of Healthcare of Russia</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Bonum Multidisciplinary Clinical Medical Center</institution></aff><aff><institution xml:lang="ru">ГАУЗ Свердловской области «Многопрофильный клинический медицинский центр «Бонум»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2022</year></pub-date><volume>8</volume><issue>1</issue><issue-title xml:lang="en">VOL 8, NO1 (2022)</issue-title><issue-title xml:lang="ru">ТОМ 8, №1 (2022)</issue-title><fpage>28</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2023-02-26"><day>26</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, “Bionika Media” LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, ООО «Бионика Медиа»</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">“Bionika Media” LLC</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://journals.eco-vector.com/2412-4036/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/2412-4036/article/view/288747">https://journals.eco-vector.com/2412-4036/article/view/288747</self-uri><abstract xml:lang="en"><p>Smell and taste impairment are among the most common symptoms of COVID-19. Aim: to assess the patterns of olfactory and taste disorders associated with COVID-19 infection and their relationship with the clinical course of the disease. Material and methods. The cross-sectional survey enrolled 10348 young adults who had experienced taste and smell impairment during the COVID-19 epidemic. The patients were interviewed using an online questionnaire specially developed for the purposes of the work. The sampling has been stratified according to the severity of the disease course: mild (Group 1), moderate (Group 2), and severe (Group 3). Results. 7964 (77%) females and 2384 (23%) males aged from 20 to 40 were enrolled. The median age was 29 (24-36) for females and 29 (24-34) for males. A mild disease course was reported in 8454 (81,6%) cases, an average severity course was registered in 1486 (14,4%) respondents, and there were 408 (4%) cases of more than 50% bilateral polysegmental lung tissue involvement. Complete anosmia and ageusia was noted by 7225 (69,8%) respondents, insolated anosmia had occurred in 2641 (25,5%) cases, and 78 (0,7%) patients noted ageusia without olfactory dysfunction. Significant differences in the frequency of restoration of taste and smell in COVID-19 patients with different course severity were revealed. Before the disease onset, 534 respondents reported non-compliance with the recommended measures of self-isolation and respiratory protection, 1841 respondents continued to work out of home and use personal protection masks, 7846 persons reported a transition to remote job regime and use of individual masks when visiting public places. Conclusion. The development of taste and olfactory sense disorders in young patients with COVID-19 was associated with the disease course severity. Patients with severe coronavirus infection were significantly more likely to have a simultaneous violation of taste and smell, patients with mild and moderate severity were more likely to have anosmia without taste impairment. By the month since the disease onset, every other patient with mild disease course still retained complete or partial anosmia and ageusia. The subjects with moderate and severe COVID-19 course more often noted the restoration of taste and sense of smell by the end of the Month 1. The rate of recovery of taste and smell in young patients with COVID-19 was associated with the severity of the disease and compliance with self-isolation measures.</p></abstract><trans-abstract xml:lang="ru"><p>Обонятельная и вкусовая дисфункция - одни из наиболее частых симптомов COVID-19. Цель - оценить характер нарушений обоняния и вкуса, ассоциированных с COVID-19, их связь с клиническими особенностями заболевания. Материал и методы. В одномоментное исследование на условиях добровольного согласия было включено 10 348 пациентов - 7964 (77%) женщины и 2384 (23%) мужчины в возрасте 29 (24+36) лет с нарушением вкуса и обоняния, возникшим в период эпидемии COVID-19. Пациенты были опрошены по специально разработанной для целей работы онлайн-анкете. Выборка была разделена на 3 группы по тяжести заболевания: группа 1 - с легкой, группа 2 - со среднетяжелой, группа 3 - с тяжелой формой COVID-19. Результаты. Медиана возраста женщин составила 29 (24-36) лет, мужчин - 29 (24-34) лет. Заболевание легкой степени перенесли 8454 (81,6%) респондента, среднюю степень имели 1486 (14,4%) пациентов, 408 (4%) человек перенесли COVID-19 в форме двухстороннего полисегмен-тарного вирус-индуцированного интерстициального поражения легочной ткани в объеме более 50%. Полное отсутствие вкуса и обоняния (аносмию и агевзию) имели 7225 (69,8%) респондентов, 2641 (25,5%) указали на полное отсутствие обоняния при сохранении вкусовых ощущений, 78 (0,7%) пациентов отметили агевзию при сохранении обоняния. Выявлены значимые различия частоты восстановления вкуса и обоняния у больных COVID-19 с различной тяжестью течения. В период, предшествовавший заболеванию, 534 респондента (5%) не соблюдали меры самоизоляции и не использовали СИЗ органов дыхания, 1841 человек (18%) работали в привычном режиме с использованием СИЗ, 7846 человек (76%) работали дистанционно и применяли СИЗ при посещении общественных мест, 127 участников (1%) не дали ответа на этот вопрос. Заключение. Развитие нарушений вкусовых и обонятельных ощущений у молодых пациентов с COVID-19 ассоциировано с тяжестью течения заболевания. Пациенты с тяжелым течением коронавирусной инфекции значимо чаще отмечали одновременное нарушение вкуса и обоняния, пациенты с легкой и средней тяжестью чаще имели аносмию при сохранении вкусовых ощущений. Через месяц после начала заболевания у каждого 2 пациента с легкой степенью сохранялась полная или частичная аносмия и/или агевзия. У перенесших COVID-19 средней и тяжелой формы значимо чаще наблюдалось восстановление вкуса и обоняния к моменту опроса. Темпы восстановления вкуса и обоняния у молодых пациентов с COVID-19 ассоциировались с тяжестью течения заболевания и соблюдением мер самоизоляции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>SARS-CoV2</kwd><kwd>anosmia</kwd><kwd>parosmia</kwd><kwd>ageusia</kwd><kwd>dysgeusia</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>patient reported outcomes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аносмия</kwd><kwd>паросмия</kwd><kwd>агевзия</kwd><kwd>дисгевзия</kwd><kwd>исходы</kwd><kwd>оцениваемые пациентами</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Welge-Lussen A., Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol. 2006; 63: 125-32. https://dx.doi.org/10.1159/000093758.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kanjanaumporn J., Aeumjaturapat S., Snidvongs K. et al. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options. Asian Pac J Allergy Immunol. 2020; 38(2): 69-77. https://dx.doi.org/10.12932/AP-030520-0826.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Huart C., Philpott C., Konstantinidis I. et al.Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. 2020; 58(6): 623-25. https://dx.doi.org/10.4193/Rhin20.251.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8): 2251-61. https://dx.doi.org/10.1007/s00405-020-05965-1.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chiesa-Estomba C.M., Lechien J.R., Radulesco T. et al. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020; 27(1 1): 2318-21. https://dx.doi.org/10.1111/ene.14440.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Parma V., Ohla K., Veldhuizen M.G. et al. More than smell - COVID-19 is associated with severe impairment of smell, taste, and chemesthesis. Chem Senses. 2020; 45(7): 609-22. https://dx.doi.org/10.1093/chemse/bjaa041.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) Версия 11» (утв. Минздравом России 07.05.2021). Доступ: https://base.garant.ru/400738625 (дата обращения - 1 1.01.2022).</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Nehme M., Braillard O., Chappuis F. et al. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021; 174(9): 1252-60. https://dx.doi.org/10.7326/M21-0878</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Kadri S.S., Sun J., Lawandi A. et al. Association between caseload surge and COVID-19 survival in 558 U.S. hospitals, March to August 2020. Ann Intern Med. 2021; 174(9): 1240-51. https://dx.doi.org/10.7326/M21-1213</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bagheri S.H., Asghari A., Farhadi M. et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran. Med J Islam Repub Iran. 2020; 34: 62. https://dx.doi.org/10.34171/mjiri.34.62</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>ENT UK. Hopkins C., Kumar N. Loss of sense of smell as marker of COVID-19 infection. URL: https://www.entuk.org/loss-sense-smell-marker-covid-19-infection (date of access - 1 1.01.2021)</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gane S.B., Kelly C., Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology. 2020; 58(3): 299-301. https://dx.doi.org/10.4193/Rhin20.114</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Saussez S., Lechien J.R., Hopkins C. Anosmia: An evolution of our understanding of its importance in COVID-19 and what questions remain to be answered. Eur Arch Otorhinolaryngol. 2021; 278(7): 2187-91. https://dx.doi.org/10.1007/s00405-020-06285-0.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lechien J.R., Chiesa-Estomba C.M., Beckers E. et al. Prevalence and 6-month recovery of olfactory dysfunction: A multicentre study of 1363 COVID-19 patients. J Intern Med. 2021; 290(2): 451-61. https://dx.doi.org/10.1111/joim.13209.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Zhang R., Li Y., Zhang A.L. et al. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci U S A. 2020; 1 17(26): 14857-63. https://dx.doi.org/10.1073/pnas.2009637117. Erratum in: Proc Natl Acad Sci U S A. 2020; 1 17(41): 25942-43.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Yuan F., Huang T., Wei Y., Wu D. Steroids and olfactory training for postviral olfactory dysfunction: A systematic review. Front Neurosci. 2021; 15: 708510. https://dx.doi.org/10.3389/fnins.2021.708510.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Saussez S., Sharma S., Thiriard A. et al. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction. Eur J Neurol. 2021; 28(1 1): 3702-1 1. https://dx.doi.org/10.1111/ene.14994.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Coelho D.H., Reiter E.R., Budd S.G. et al. Predictors of smell recovery in a nationwide prospective cohort of patients with COVID-19. Am J Otolaryngol. 2022; 43(1): 103239. https://dx.doi.org/10.1016/j.amjoto.2021.103239.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Hura N., Xie D.X., Choby G.W. et al. Treatment of post-viral olfactory dysfunction: An evidence-based review with recommendations.Int Forum Allergy Rhinol. 2020; 10(9): 1065-86. https://dx.doi.org/10.1002/alr.22624.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Massachusetts Medical Society. Patient-reported outcome measures: Current state and MMS principles. URL: www.massmed.org/proms (date of access - 11.01.2022).</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Леонова М.В. Оценка исходов пациентами в клинических исследованиях. Качественная клиническая практика. 2016; 2: 38-45.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Иванова А.А. Применение Big Data в сфере здравоохранения: российский и зарубежный опыт. Научные записки молодых исследователей. 2020; 5: 42-53</mixed-citation></ref></ref-list></back></article>
